Thema: CH0499880968
ADCT, CH0499880968
gamestop-6286878_1920.jpg - Foto: THN
ADC Therapeutics stock faces FDA hurdles as runway extends to 2029
ADC Therapeutics stock followed quarterly results that showed stronger product sales and a narrower loss. New ZYNLONTA data could shape the next phase.
ad-hoc-news.de, heute 03:24 Uhr
ADCT, CH0499880968
ADC Therapeutics secures USD 86.6 million PIPE for ADC Therapeutics ...
The deal is designed to extend cash runway into 2029. For ADC Therapeutics stock, 48.1 million warrants add dilution context.
ad-hoc-news.de, 19.10.26 01:56 Uhr
ADCT, CH0499880968
ADC Therapeutics stock gained 8.27 percent to USD 1.38
ADC Therapeutics stock saw 816,530 shares traded on October 7, 2026, while it sat 72.3 percent below its USD 4.98 yearly high. Q2 cash reached USD 219.1 million.
ad-hoc-news.de, 08.10.26 04:09 Uhr
ADCT, CH0499880968
MarketBeat reports a USD 5.00 target for ADC Therapeutics ...
Second-quarter revenue reached USD 19.25 million versus USD 18.89 million consensus. Six analysts cover ADC Therapeutics stock, with three Buy ratings.
ad-hoc-news.de, 05.10.26 03:14 Uhr
ADCT, CH0499880968
ADC Therapeutics stock gained 4.63 percent as analysts held ...
